MKI67 and neoplasm: HER2-low tumors had larger primary tumor sizes (p = 0.007) and more nodal involvement (p = 0.010); there were no differences in Ki67 scores or in the percentage of tumor-infiltrating lymphocytes (TILs) between HER2-zero and HER2-low expression [6].